过去一年中添加的文章，按日期排序
[HTML][HTML] Efficacy and safety of drugs in residual cardiovascular risk: a systematic review of the literature
MA Hernandez-Sómerson, F Montoya-Agudelo… - … Cardiovascular Risk …, 2024 - Elsevier
18 天前 - … A table with the findings, including an evaluation of the … Colchicine reduces the risk
of MACE in subjects with … Il–6 improves cardiovascular outcomes independently of the level …
of MACE in subjects with … Il–6 improves cardiovascular outcomes independently of the level …
Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial
26 天前 - … A separate systematic review conducted in 2021 examined the … of colchicine for
the prevention of cardiovascular outcomes in randomised trials of patients with coronary artery …
the prevention of cardiovascular outcomes in randomised trials of patients with coronary artery …
… RISK OF CARDIOVASCULAR EVENTS AFTER FIRST GOUT FLARE CONSULTATION IN PRIMARY CARE: A SELF-CONTROLLED CASE SERIES ANALYSIS …
32 天前 - … 147 (7.9%) had a prescription for anti-inflammatory medications (NSAIDs, colchicine,
or corticosteroids) in the previous 60 days. The incidence of cardiovascular events was …
or corticosteroids) in the previous 60 days. The incidence of cardiovascular events was …
… CARDIOVASCULAR EVENTS IN PATIENTS WITH GOUT STARTING URATE-LOWERING THERAPY WITH OR WITHOUT FLARE PROPHYLAXIS WITH COLCHICINE …
32 天前 - … with cardiovascular events (CVEs). Clinical trials show that low-dose colchicine
reduces the risk of CVEs in patients with atherosclerotic cardiovascular diseases [1,2]. …
reduces the risk of CVEs in patients with atherosclerotic cardiovascular diseases [1,2]. …
AB0107 ANAKINRA TREATMENT OF ACUTE CPPD CRYSTAL ARTHRITIS WITH CERVICAL SPINE INVOLVEMENT (CROWNED DENS SYNDROM)-IS IT WORTH …
R Lunzer, E Wipfler-Freißmuth - 2024 - ard.bmj.com
32 天前 - … Whether this would have been possible with significantly cheaper therapy options,
such as glucocorticoids or colchicine, can only be assumed. The existing comorbidities in …
such as glucocorticoids or colchicine, can only be assumed. The existing comorbidities in …
TNF inhibitors and cardiovascular risk: Friend or foe?
JM Gelfand, M Garshick - Journal of the European Academy of …, 2024 - Wiley Online Library
39 天前 - … treatments canakinumab and colchicine have been … CV outcomes despite the
predicted beneficial effects based on clinical and preclinical data. More recently, a meta-analysis …
predicted beneficial effects based on clinical and preclinical data. More recently, a meta-analysis …
Inflammation and Cardiovascular Outcomes
P Satish, A Agarwala - Cardiovascular Outcomes Research: A Clinician's …, 2024 - Springer
40 天前 - … Disease (LoDoCo) trial was an open-label trial that randomized 532 patients with
… 0.5 mg colchicine daily or no colchicine. At the 3-year follow-up, patients on colchicine had a …
… 0.5 mg colchicine daily or no colchicine. At the 3-year follow-up, patients on colchicine had a …
Managing chronic coronary syndrome: how do we achieve optimal patient outcomes?
AA Manolis, TA Manolis, AS Manolis - … Review of Cardiovascular …, 2024 - Taylor & Francis
47 天前 - … as an important contributor to MACE and CV outcomes and … An analysis of MHR
in over 400 male patients with chest … However, colchicine should not be given to patients with …
in over 400 male patients with chest … However, colchicine should not be given to patients with …
Magnitude of Effect of Low Dose Colchicine, a Newly FDA Approved Treatment for Stroke Prevention (P10-5.003)
E Escalera, J Saver - Neurology, 2024 - AAN Enterprises
84 天前 - … search for RCTs of long-term colchicine use in patients with atherosclerosis
indications published from 2000–2023 and study-level meta-analysis using RevMan software. …
indications published from 2000–2023 and study-level meta-analysis using RevMan software. …
Efficacy of Colchicine in Coronary Disease: Bayesian Analysis and Null-Hypothesis Testing
G Nakhlé, JC Tardif, MP Dubé, A Dubois… - Available at SSRN … - papers.ssrn.com
90 天前 - … colchicine. • The risk reduction probabilities with Colchicine were high for all CV
outcomes. … In an analysis of the primary endpoint of LoDoCo211 by country, Brophy obtained a …
outcomes. … In an analysis of the primary endpoint of LoDoCo211 by country, Brophy obtained a …